Sol-Gel Technologies (SLGL) Return on Sales (2018 - 2026)
Sol-Gel Technologies (SLGL) reported Return on Sales of 0.36% for Q1 2026, up 27.0% year-over-year from 0.28% in Q1 2025, and up 828.33% quarter-over-quarter from 0.05% in Q4 2025.
Sol-Gel Technologies (SLGL) Return on Sales (2018 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 9 years of Return on Sales data on file, last reported at 0.36% in Q1 2026.
- Return on Sales for Q1 2026 came in at 0.36%, up 27.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, up 1.0% from the prior year.
- Return on Sales advanced to 0.36% in Q1 2026 per SLGL's latest filing, from 0.05% in the prior quarter.
- Over five years, Return on Sales peaked at 0.36% in Q1 2026 and troughed at 0.62% in Q4 2022.
- A 5-year average of 0.08% and a median of 0.05% in 2025 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2022 and 2023: Return on Sales plunged 63 bps in 2022, then soared 50 bps in 2023.
- A 5-year view of Return on Sales shows it stood at 0.62% in 2022, then surged by 81 bps to 0.12% in 2023, then plunged by 81 bps to 0.22% in 2024, then soared by 78 bps to 0.05% in 2025, then surged by 828 bps to 0.36% in 2026.
- Business Quant data shows SLGL's Return on Sales at 0.36% in Q1 2026, 0.05% in Q4 2025, and 0.16% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Sol-Gel Technologies | 207.80 Mn | 197.67 Mn | - | 0.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.36% |
| Dec 31, 2025 | -0.05% |
| Sep 30, 2025 | -0.16% |
| Jun 30, 2025 | 0.01% |
| Mar 31, 2025 | 0.09% |
| Dec 31, 2024 | -0.22% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Dec 31, 2023 | -0.12% |
| Sep 30, 2023 | -0.30% |
| Jun 30, 2023 | -0.11% |
| Dec 31, 2022 | -0.62% |
| Sep 30, 2022 | -0.14% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.01% |
| Sep 30, 2021 | 0.01% |
| Jun 30, 2021 | 0.09% |
| Mar 31, 2021 | 0.06% |
| Dec 31, 2020 | -0.03% |